Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
EVMN · against 1,336 other Healthcare companies
Ranked #857 of 1,337 · scores higher than 33% of peers
Bars: peers in each 10-point band of the valuation score133 peers with a valuation score of 30–39, including EVMN · Click a bar to see the companies
Mainly because of its earnings yield and free cash flow yield, which are weaker than most Healthcare peers.
| Metric | EVMN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | -199.8% | 1.5% | 1% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | -434.7% | 4.2% | 1% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | -34.6% | -1.0% | 8% | 20% | |
| Book yieldHigher is better · 1,306 reported | 128.8% | 37.9% | 92% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 857 | 110M USD | 33 | 38 | |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 857 |
| 4.5B USD |
| 33 |
| 33 |
| 857 | 213M USD | 33 |
| 857 | 109M USD | 33 | 47 |
| 857 | 216M USD | 33 | 44 |
| 857 | 34M USD | 33 | 19 |
| 857 | 126M USD | 33 | 32 |
| 857 | 285M USD | 33 | 38 |
| 857 | 338M USD | 33 |